A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

The AI tool, called MindGlide, developed by researchers from the University College London (UCL) uses mathematical models to ...

In the UK, 130,000 people live with MS ... Using MindGlide will enable us to use existing brain images in hospital archives to better understand multiple sclerosis and how treatment affects the brain.

Researchers at UCL have developed an innovative AI tool called MindGlide, designed to transform the way MS treatments are ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study ...

People on disability benefits including Personal Independence Payment (PIP), Adult Disability Payment (ADP), Attendance Allowance, Disability Living Allowance (DLA) and more, can join a unique, free ...

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis (MS), such as brain shrinkage and lesions.

MindGlide is an AI tool from UCL that can help interpret and assess how well treatments are working for people with MS.

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to treatment in MS.